Advertisement
News
Subscribe to MDT Magazine News

Omthera Pharmaceuticals, Inc. to Present at the BIO Windhover/Pharmaceutical Strategic Outlook 2011 Conference

March 24, 2011 6:34 am | by Bio-Medicine.Org | Comments

BEDMINSTER, N.J., March 24, 2011 /- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that Jerry Wisler, President and Chief Executive Officer, will present at the BIO Windhover/Pharmaceutical Strategic Outlook 2011 Conference at...

TOPICS:

Christiana Care Health System Leads National Colorectal Cancer Clinical Trial

March 24, 2011 6:34 am | by Bio-Medicine.Org | Comments

WILMINGTON, Del., March 24, 2011 /PRNewswire-USNewswire/ -- Christiana Care Health System's Helen F. Graham Cancer Center is leading a national clinical trial to determine if Crestor® (Rosuvastatin), a cholesterol-lowering drug, can prevent new colon tumors from forming after colon...

TOPICS:

Solos Endoscopy, Inc. Strengthens Current Line of Laparoscopic Instruments

March 24, 2011 6:32 am | by Bio-Medicine.Org | Comments

BOSTON, March 24, 2011 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company has strengthened its current line of Laparoscopic surgical instruments in order to better align its product offerings with current global endoscopy market trends. Solos has focused...

TOPICS:
Advertisement

American Imaging Management Promotes Affordability and Choice to Health Care Consumers

March 24, 2011 6:32 am | by Bio-Medicine.Org | Comments

CHICAGO, March 24, 2011 /- A new program from American Imaging Management (AIM) delivers valuable information to physicians and consumers regarding the price of advanced diagnostic imaging exams and the quality of the facilities where those exams are performed, offering significant cost...

TOPICS:

Scrushy possessions selling in huge yard sale

March 24, 2011 5:45 am | by RUSSELL HUBBARDAssociated Press | Comments

The big barn and horse stables that were a symbol of Richard Scrushy's rags-to-riches tale as the chief executive of HealthSouth Corp. will be overrun this weekend by strangers combing through the last of his personal possessions.The horse buildings on the Vestavia Hills home place will be the...

TranS1 gets FDA approval for product

March 24, 2011 5:45 am | by The Associated Press | Comments

Medical device maker TranS1 Inc. said Thursday it received Food and Drug Administration clearance for a spinal implant system.Shares surged $1.13, or 35 percent, to $4.39 in premarket trading.TranS1 said it received clearance for the "AxiaLIF 1L+" product line, an instrumentation and implant...

PerkinElmer paying $220M for CambridgeSoft and ArtusLabs

March 24, 2011 5:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Waltham-based life sciences and environmental tech giant PerkinElmer Inc. plans to acquire life sciences software firm CambridgeSoft Corp., and has already completed the purchase of ArtusLabs Inc. of Durham, N.C., paying a combined $220 million for the companies.

BL Healthcare brings Series A up to $5M

March 24, 2011 5:32 am | by Mass High Tech: The Journal of New England Technology | Comments

BL Healthcare Inc., a Foxborough-based developer of electronic technology for health care, has bumped up a previous funding round from $5 million to $6 million, and boosted the amount of that round it has received from $3 million to $5 million.

Advertisement

Gilead Sciences offering $1 billion in notes

March 24, 2011 4:45 am | by The Associated Press | Comments

Biotechnology company Gilead Sciences Inc. said Wednesday it is publicly offering $1 billion in notes.The company said the notes will mature on April 1, 2021, and will bear interest at an annual rate of 4.5 percent. The offering is expected to close March 30, 2011.Gilead intends to use the...

Gateway to Hope: Missouri Nonprofit Leads the Fight against Breast Cancer by Providing Donated Medical and Surgical Care at No Cost to Patients

March 24, 2011 4:34 am | by Bio-Medicine.Org | Comments

ST. LOUIS, March 24, 2011 /- Frustrated at seeing patients die because of lack of insurance or financial means, Dr. David A. Caplin and Dr. Marlys E. Schuh founded Gateway to Hope in St. Louis, Missouri in 2005. Based on the belief that every person diagnosed with breast cancer should be...

TOPICS:

Henry Schein Ranks #1 in Its Industry for Social Responsibility as a Fortune 2011 World's Most Admired Company

March 24, 2011 4:34 am | by Bio-Medicine.Org | Comments

MELVILLE, N.Y., March 24, 2011 /- Henry Schein, Inc. (Nasdaq: HSIC ), the largest distributor of health care products and services to office-based dental, medical and veterinary practitioners, has been ranked number one in the "Wholesalers:  Health Care" industry in Fortune...

TOPICS:

Reportlinker Adds Triple Analysis: Colorectal Cancer, Lung Cancer and Lymphoma

March 24, 2011 4:33 am | by Bio-Medicine.Org | Comments

NEW YORK, March 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Colorectal Cancer, Lung Cancer and Lymphoma http://www.reportlinker.com/p0284975/Triple-Analysis-Colorectal-Cancer-Lung-Cancer-and-Lymphoma.html This...

TOPICS:

Reportlinker Adds Therapeutics for Immune System Disorders

March 24, 2011 4:32 am | by Bio-Medicine.Org | Comments

NEW YORK, March 24, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Therapeutics for Immune System Disorders http://www.reportlinker.com/p0461662/Therapeutics-for-Immune-System-Disorders.html In 2010, the global market for drugs for the...

TOPICS:

VTI starts volume production of the CMR3000 3-axis gyro sensor

March 23, 2011 9:37 pm | by I-Micronews | Comments

VTI Technologies has started volume production of the world's smallest and lowest power consuming digital output 3-axis angular rate sensor, the CMR3000.

A Genomic Blueprint for Cancer

March 23, 2011 8:32 pm | by Massachusetts Institute of Technology | Comments

The largest cancer genome sequencing project yet highlights molecular pathways at the heart of an aggressive blood cancer.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading